A Phase 2 Study of Chemoembolization in People With Non-Small Cell Lung Cancer

Share

Full Title

Phase II Trial of Lung Chemoembolization

Purpose

Researchers are doing this study to learn if lung chemoembolization is safe and works well in people with lung cancer. The people in this study have non-small cell lung cancer that keeps growing after chemotherapy. Moreover, it cannot be cured with surgery or radiation therapy.

Chemoembolization combines two treatments: chemotherapy and embolization. Chemotherapy is first given through an artery that supplies blood directly to the tumor. The chemotherapy in this study is mitomycin. Next, the blood supply to the tumor is embolized (blocked) using small plastic beads injected into the artery. Embolization allows a high amount of chemotherapy to reach the tumor for a long time and kill cancer cells.

Who Can Join

To join this study, there are a few conditions. You must:

  • Have non-small cell lung cancer that keeps growing even though you got chemotherapy.
  • Be able to walk and do routine activities for more than half the time you are awake.
  • Be age 18 or older.

Contact

For more information or to see if you can join this study, please call Dr. Stephen Solomon’s office at 212-639-5012.

Protocol

24-176

Phase

Phase II (phase 2)

Investigator

Co-Investigators

ClinicalTrials.gov ID

NCT05672108